India's first dengue vaccine is nearing rollout as a study maps circulating virus strains. All four dengue serotypes are now circulating si...

When companies from a sector with a clear growth path get listed, too much money flows into them, sending valuations high. What follows is ...

Artificial intelligence is often hailed as a game changer, but too many firms discover that their bold AI pilots collapse when their operat...

India's startup revolution is spreading beyond metros, with young innovators from tier-2 and tier-3 cities building scalable solutions. Bet...

Healthcare Global Enterprises is using artificial intelligence and patient data. Algorithms are being developed to personalise cancer treat...

The startup aims to replace costly and invasive scans with an AI-powered diagnostic platform tailored for the Indian population. Enlife on ...

Avience Biomedicals made a spectacular debut on the NSE SME platform, with its shares rocketing 90% on listing day. The Rs 30.24 crore IPO,...

A gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...

The grey market premium (GMP) for the issue stood at 36% ahead of the opening, implying an unofficial market price of around Rs 283 against...

Precision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...

Q-Line Biotech is poised for a strong stock market debut on Friday. Investor demand appears robust, with grey market trends showing a signi...

Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating ...

Brokerage firm Nuvama expects Kilpest India to sustain healthy growth in the molecular diagnostics business, led by product launches, acqui...

POSTECH announced on the 10th that a research team led by Professor Lee Jung-wook of the Department of Chemical Engineering has developed m...

Molecular diagnostics companies have expressed concern after the government on Saturday decided to ban export of all diagnostic kits and re...

Private molecular diagnostic companies have received licenses to get their tests validated but they cannot sell those kits under the curren...

Molbio along with its subsidiary Bigtec Labs, has developed and commercialised Truenat, which is claimed to be the world's first commercial...